WT Cefalu, FB Hu - Diabetes Care, 2004 - Am Diabetes Assoc Despite widespread use by patients with diabetes and anecdotal reports in the
past regarding its efficacy, until recently, data in humans concerning
chromium's effects on insulin action in vivo or on cellular aspects of ... Cited by 83 - Related articles - All 5 versions
- ►diabetesjournals.org [PDF] J Komorowski, V Juturu - Diabetes Care, 2005 - Am Diabetes Assoc Clinical indexes of insulin resistance (IR) have acquired increasing im-
portance with the development of various drugs that improve endogenous insulin
action (1). Recently, the largest database on insulin clamp studies has ... Cited by 28 - Related articles - BL Direct - All 10 versions
- ►diabetesjournals.org S Rajpathak, EB Rimm, T Li, JS Morris, MJ … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Mean toenail chromium (μg/g) was 0.71 in healthy control subjects,
0.61 in diabetes-only subjects, and 0.52 in diabetic subjects with prevalent CVD
(P for trend = 0.003). In the cross-sectional analysis, the multivariate ... Cited by 35 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org N Kleefstra, ST Houweling, FGA Jansman, KH … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this 6-month double-blind study, patients with
an HbA 1c (A1C) >8% and insulin requirements of >50 units/day were randomly
assigned to receive treatment with placebo or 500 or 1,000 μg chromium ... Cited by 35 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org J Martin, ZQ Wang, XH Zhang, D Wachtel, J … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Thirty-seven subjects with type 2 diabetes were
evaluated. After baseline, subjects were placed on a sulfonylurea (glipizide
gastrointestinal therapeutic system 5 mg/day) with placebo for 3 months. ... Cited by 50 - Related articles - BL Direct - All 9 versions
- ►cnfindpark.cn MD Althuis, NE Jordan, EA Ludington, JT … - American Journal of Clinical Nutrition, 2002 - ajcn.cnfindpark.cn Background: Several authors, mostly on the basis of nonrandomized studies, have
suggested dietary trivalent chromium supplementation as an attractive option for
the management of type 2 diabetes and for glycemic control in persons at ... Cited by 113 - Related articles - BL Direct - All 8 versions
- ►nutrition.org WT Cefalu, ZQ Wang, XH Zhang, LC Baldor, … - Journal of Nutrition, 2002 - Am Soc Nutrition Human studies suggest that chromium picolinate (CrPic) decreases insulin levels
and improves glucose disposal in obese and type 2 diabetic populations. To
evaluate whether CrPic may aid in treatment of the insulin resistance ... Cited by 89 - Related articles - BL Direct - All 5 versions
MH Pittler, C Stevinson, E Ernst - International Journal of Obesity, 2003 - nature.com The aim of this meta-analysis was to assess the evidence of chromium picolinate
for reducing body weight. Literature searches were conducted on Medline, Embase,
The Cochrane Library, Amed and Ciscom. Nine experts and four manufacturers ... Cited by 64 - Related articles - BL Direct - All 5 versions
WT Cefalu - The Nutritional Biochemistry of Chromium (III), 2007 - books.google.com Chapter 8 Clinical effect of chromium supplements on human health William T.
Cefalu Pennington Biomedical Research Center, Louisiana State University System,
6400 Perkins Road, Baton Rouge, LA 70808 INTRODUCTION The primary clinical ... Related articles
M Vrtovec, B Vrtovec, A Briski, A Kocijancic … - American Heart Journal, 2005 - Elsevier Although baseline QTc interval was similar in both groups (422 ± 34
milliseconds in group A vs 425 ± 24 milliseconds in group B, P = .77), QTc
interval at 3 months was shorter in group A (406 ± 35 milliseconds) than ... Cited by 13 - Related articles - All 23 versions
